Kenneth Hoberman - 11 Jun 2026 Form 4 Insider Report for TG THERAPEUTICS, INC. (TGTX)

Reporting relationship: Director
Issuer ticker: TGTX
Reported as of: 11 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Jun 2026, 17:02:04 UTC
Prior SEC filing: 16 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Kenneth Hoberman

Key filing fact

Kenneth Hoberman filed Form 4 for TG THERAPEUTICS, INC. (TGTX) on 15 Jun 2026.

Key facts

This page summarizes Kenneth Hoberman's Form 4 filing for TG THERAPEUTICS, INC. (TGTX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 15 Jun 2026, 17:02.

Change

Previous filing in this sequence was filed on 16 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001573722 Primary reporting owner

Hoberman Kenneth

Relationship: Director
Address: 3020 CARRINGTON MILL BLVD, SUITE 475, MORRISVILLE
Signature: /s/ Kenneth Hoberman
Signature date: 15 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TGTX transaction Derivative

Stock Tracking Unit

Award

Transaction value
Shares: +8,325
Change %
Price: $0.000000^*
Shares after: 8,325
Date: 11 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,325
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each stock tracking unit ("STU") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant.

Footnote F2

Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant.